ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer

Clinical trial NCT06570031 · COMPLETED

Trial details

NCT number: NCT06570031
Sponsor: Ono Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hormone Receptor-positive Breast Cancer HER2-negative Breast Cancer Metastatic Breast Cancer Recurrent Breast Cancer

Start date: 2021-11-09
Primary completion: 2026-04-30
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.